A109820 logo

GeneMatrix Inc. Stock Price

KOSDAQ:A109820 Community·₩47.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A109820 Share Price Performance

₩2,340.00
-340.00 (-12.69%)
₩2,340.00
-340.00 (-12.69%)
Price ₩2,340.00

A109820 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very low risk with weak fundamentals.

2 Risks
0 Rewards

GeneMatrix Inc. Key Details

₩4.7b

Revenue

₩2.9b

Cost of Revenue

₩1.8b

Gross Profit

₩3.9b

Other Expenses

-₩2.1b

Earnings

Last Reported Earnings
Sep 30, 2019
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About A109820

Founded
2000
Employees
n/a
CEO
Soook Kim
WebsiteView website
www.genematrix.net

GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and controls. The company was founded in 2000 and is headquartered in Seongnam, South Korea.

Recent A109820 News & Updates

Recent updates

No updates